ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,567.19
1.06%
Dow Jones
39,375.87
0.17%
US Dollar vs MXN
18.1111
0.01%
Brent Oil
86.775
0.00%
Bitcoin
56,709.44
0.11%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. IsoPlexis Corporation (ISO)

  7. IsoPlexis Corporation (ISO) Noticias

ISO

IsoPlexis (ISO)

IsoPlexis Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ISO
FechaHoraFuenteTítuloSímboloCompañía
15/06/202315:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ISOIsoPlexis Corporation
31/03/202307:33Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ISOIsoPlexis Corporation
22/03/202307:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ISOIsoPlexis Corporation
21/03/202315:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ISOIsoPlexis Corporation
21/03/202308:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ISOIsoPlexis Corporation
21/03/202307:02PR Newswire (US)Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology CompanyNASDAQ:ISOIsoPlexis Corporation
16/03/202316:29Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ISOIsoPlexis Corporation
09/03/202315:34Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ISOIsoPlexis Corporation
02/03/202307:16Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ISOIsoPlexis Corporation
14/02/202315:54Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ISOIsoPlexis Corporation
12/01/202315:05GlobeNewswire Inc.IsoPlexis Reports Preliminary Full Year 2022 RevenueNASDAQ:ISOIsoPlexis Corporation
21/12/202217:52Dow Jones NewsStocks to Watch: IsoPlexis, Lexicon Pharma, Micron Tech, Berkeley LightsNASDAQ:ISOIsoPlexis Corporation
21/12/202215:49GlobeNewswire Inc.Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology CompanyNASDAQ:ISOIsoPlexis Corporation
11/11/202206:35TipRanksSVB Securities Sticks to Their Hold Rating for IsoPlexis (ISO)NASDAQ:ISOIsoPlexis Corporation
10/11/202215:12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ISOIsoPlexis Corporation
10/11/202206:00GlobeNewswire Inc.IsoPlexis Reports Third Quarter 2022 Financial ResultsNASDAQ:ISOIsoPlexis Corporation
09/11/202206:00GlobeNewswire Inc.IsoPlexis to Participate in Upcoming Investor ConferencesNASDAQ:ISOIsoPlexis Corporation
19/10/202206:00GlobeNewswire Inc.IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022NASDAQ:ISOIsoPlexis Corporation
13/09/202206:00GlobeNewswire Inc.IsoPlexis Announces First APAC Publication, Illustrating Early Impact of Codeplex PlatformNASDAQ:ISOIsoPlexis Corporation
06/09/202206:00GlobeNewswire Inc.IsoPlexis Partners with MediMergent and The Center for Cancer and Blood Disorders in Study of AZD7442 for Prevention of COVID-19 Infection in Immuno-Compromised Cancer PatientsNASDAQ:ISOIsoPlexis Corporation
31/08/202206:00GlobeNewswire Inc.IsoPlexis to Participate in the Morgan Stanley Global Healthcare ConferenceNASDAQ:ISOIsoPlexis Corporation
24/08/202208:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ISOIsoPlexis Corporation
23/08/202206:00GlobeNewswire Inc.IsoPlexis Announces the Appointment of former Luminex Corporation Chairman and CEO, Nachum “Homi” Shamir to its Board of DirectorsNASDAQ:ISOIsoPlexis Corporation
10/08/202206:00GlobeNewswire Inc.IsoPlexis Reports Second Quarter 2022 Financial ResultsNASDAQ:ISOIsoPlexis Corporation
21/07/202206:00GlobeNewswire Inc.IsoPlexis to Report Second Quarter 2022 Financial Results on August 10, 2022NASDAQ:ISOIsoPlexis Corporation
31/05/202207:32Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:ISOIsoPlexis Corporation
15/05/202209:30TipRanksMorgan Stanley Thinks IsoPlexis’ Stock is Going to RecoverNASDAQ:ISOIsoPlexis Corporation
11/05/202206:00GlobeNewswire Inc.IsoPlexis Reports First Quarter 2022 Financial ResultsNASDAQ:ISOIsoPlexis Corporation
29/04/202210:40Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:ISOIsoPlexis Corporation
27/04/202215:04Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ISOIsoPlexis Corporation
 Showing the most relevant articles for your search:NASDAQ:ISO

Su Consulta Reciente

BIT
P21TU7
NLBNPIT21TU7 20241220 37.5
BIT
F18497
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados